KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Return on Assets (2016 - 2025)

Teva Pharmaceutical Industries' Return on Assets history spans 9 years, with the latest figure at 0.03% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Assets rose 8.0% year-over-year to 0.03%, compared with a TTM value of 0.03% through Dec 2025, up 8.0%, and an annual FY2025 reading of 0.04%, up 8.0% over the prior year.
  • Return on Assets for Q4 2025 was 0.03% at Teva Pharmaceutical Industries, up from 0.02% in the prior quarter.
  • The five-year high for Return on Assets was 0.03% in Q4 2025, with the low at 0.08% in Q1 2021.
  • Average Return on Assets over 5 years is 0.03%, with a median of 0.03% recorded in 2022.
  • Biggest YoY gain for Return on Assets was 10bps in 2021; the steepest drop was -8bps in 2021.
  • Tracing TEVA's Return on Assets over 5 years: stood at 0.01% in 2021, then crashed by -710bps to 0.06% in 2022, then soared by 75bps to 0.01% in 2023, then crashed by -235bps to 0.05% in 2024, then skyrocketed by 172bps to 0.03% in 2025.
  • Per Business Quant, the three most recent readings for TEVA's Return on Assets are 0.03% (Q4 2025), 0.02% (Q3 2025), and 0.0% (Q2 2025).